Nan-O-Sil ASD Colloidal Silica Significantly Reduces the Cycle Time in Injection Molding

PP unfilled, Nylon 6, unfilled, Nylon 66, 33% glass, PBT unfilled,
PC + 33% glass, PPS, PEEK, Acetal, and Rigid PVC (read more: PVC Results Summary | Nanosil ASD Study)

Penn State University Study


“A Study on the Effect of Nan-O-Sil ASD on Cooling Time Reduction” was undertaken by Jonathan Meckley, Pennsylvania State University at Erie, The Behrend College , Erie, PA (see technical paper 1) that will be presented at ANTEC in May 2010, that demonstrated the Nan-O-Sil ASD additive can reduce cycle time by as much as 70% in semi-crystalline materials.

In PP the cooling time was reduced 77%.

In glass filled PBT, it is 70%.

Glass-filled Nylon has a 67% reduction without negative physical properties.

 

Read More »

Nan-O-Sil ASD


A unique colloidal silica processing aid from Energy Strategy Associates, Inc. slashes molding cycle times. Ultra-fine bright white silica particles have been shown in laboratory and commercial field trials to reduce injection molding cycle times by 20% to 30% in polypropylene, filled and unfilled nylon, PBT, Acetal, glass filled PC, PPS, PEEK, and Rigid PVC (read more: PVC Results Summary | Nanosil ASD Study). This processing advantage is accompanied by retention and improvements in key physical properties at low loadings (0.8% wt.).

Nan-O-Sil ASD additive is an ultra high purity, amorphous (no crystallinity), colloidal fumed silica where the particles are discrete and non agglomerated in the form of a bright white powder. Importantly the individual particles are spherical shaped and range in particle size from 0.02 to 0.55 microns (20 to 550 manometers).

Nan-O-Sil ASD improves color dispersion. Blues are bluer. Greens are greener. Nan-O-Sil ASD reduces flow lines and surface defects. Nan-O-Sil ASD is easy to mix with resin pellets in a blender so melt pre-compounding is not required.

   login  |  register       you are here : health. Am > health centers > heart diseases health center heart diseases: overview, causes, symptoms, risk factors, treatment [last updated: monday, 08 october 2012, 09:54 -08:00] pacemaker could help more heart failure patients a new study from karolinska institutet demonstrates that a change in the ecg wave called the qrs prolongation is associated with a higher rate of heart-failure… - full story - »»»     brief overview of heart failure heart failure is a varied clinical syndrome with a complex pathophysiology that is still being defined. viagra over the counter boots These features have led to demanding therapeutic regimens that have made optimal management of heart failure a difficult enterprise. reviews on viagra In addition, heart failure is common, and its public heath consequences are ever growing. viagra online An estimated 4. viagra without prescription 8 million individuals are afflicted with this syndrome in the united states today, and 400,000 to 700,000 new cases are estimated to develop each year. buy viagra without prescription The prevalence of heart failure increases with age; it approaches 10% of americans in the ninth decade of life. sales of viagra Aging of the population and the prolonged survival of patients with a variety of cardiovascular diseases that culminate in ventricular dysfunction ensure that the magnitude of the heart failure problem will substantially worsen in the next decade. Experts have projected a 2- to 3-fold increase in prevalence. is viagra a prescription drug in the uk In addition... viagra generic Other top stories   boston children’s surgeons…  study suggests stem cell transplant…  moderate drinking linked to…  alere reaches deal with fda…  world heart federation says…  undertreatment of common heart…  heart attack patients treated…  cardiovascular disease community…  restless legs, heart disease…  stressed at work? viagra safe if you have high blood pressure Look out… about heart diseases heart disease heart disease and diet heart attack bradycardia coronary artery disease coronary heart disease ischemic heart disease high blood pressure coronary artery spasm atherosclerosis heart attacks heartbeat sensations pounding heart congenital heart disease arteriosclerotic heart disease cyanotic heart disease contents symptoms and warning signs heart attack symptoms what are the symptoms first aid - cardiac arrest heart attack warning signs tachycardia bradycardia risk factors hiv & heart disease risk osteoarthritis & heart disease anemia & heart disease short legs & heart disease risk tamoxifen & heart disease risk optimism & heart disease risk antidepressant & heart attack risk tomato juice & heart disease risk high-dose steroids & heart disease risk cox drugs cause heart disease fear of terror & heart disease risk stress & heart disease risk underactive thyroid & heart di. viagra cheap canadian pharmacy http://sweet-vibrations.com/tkj-generic-viagra-online-canada-cost-bk/
Neat PP @ 90s Cooling Time:

Nan-O-Sil ASD PP @ 90s Cooling Time


Subsequent to this paper/study we have determined that the cycle time reduction provided by Nan-O-sail is a function of nucleation dynamics (see Thermal Kinetics Study)

Major Key Benefits of Nan-O-Sil


  • Nanosil ASD reduces the Injection Molding Cycle time by 30 % to 40 % for most plastics resins like PP, PE, nylons, PBT, PC, LCP, PEEK, and Rigid PVC (read more: PVC Results Summary | Nanosil ASD Study).
  • Nanosil ASD reduces and often eliminates warpage of a molded parts such as rectangular boxes, and other complex geometries.
  • Nanosil ASD Significantly improves the color dispersion and hence it helps to cut down the color concentrate amount resulting in enormous cost savings.
  • Nanosil ASD improves critical part tolerances.
  • Nanosil ASD improves strength properties like tensile strength and toughness of many resins like nylons, PP, PE, and PBT.
  • Nanosil ASD reduces the flow lines and weld lines and improves the overall dimensional stability of the molded parts.
  • It only requires less than 1% (0.8%) of Nanosil ASD (less than three cents of the cost of this additive) to attain all the above benefits.

To obtain a sample for your trials, please contact:
Richard Oder
Energy Strategy Associates
Phone: 518-794-0082
Email : R.Oder@nanosilasd.com
Website : www.nanosilasd.com